For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 11,412 | 14,348 | 13,149 | 15,381* |
| General and administrative | 5,954 | 9,873 | 6,668 | 4,592* |
| Total operating expenses | 17,366 | 24,221 | 19,817 | 19,973 |
| Operating loss | -17,366 | -24,221 | -19,817 | -19,973* |
| Interest and other income, net | 1,195 | 1,447 | 1,682 | 1,371 |
| Loss from change in fair value of embedded derivative liability | - | - | -15 | - |
| Total non-operating income, net | 1,195 | 1,447 | 1,667 | 1,371* |
| Net loss | -16,171 | -22,774 | -18,150 | -18,603* |
| Net unrealized gain (loss) on marketable debt securities | -162 | -2 | 56 | 18* |
| Comprehensive loss | -16,333 | -22,776 | -18,094 | -18,585 |
| Basic EPS | -0.16 | -0.22 | -0.18 | -0.245 |
| Diluted EPS | -0.16 | -0.22 | -0.18 | -0.245 |
| Basic Average Shares | 104,040,292 | 103,687,064 | 103,422,647 | 75,999,290 |
| Diluted Average Shares | 104,040,292 | 103,687,064 | 103,422,647 | 75,999,290 |
Rezolute, Inc. (RZLT)
Rezolute, Inc. (RZLT)